Go To Main content
Unit_Image
Back
Font: S M L
:::

::: Song-Ling Tang

🧪 PHARMACEUTICAL SCIENCE
Teacher Photo
Sung-Ling Tang  
Associate Professor
📞 Contact Information
Office: 9F, Room 9311
Tel: +886-2-87923100 ext.18856
Email: tangling@mail.ndmutsgh.edu.tw
🏛 Current Position
Associate professor
🎓 Education
2019 Ph.D., Graduate Institute of Applied Science and Technology, National Taiwan University of Science and Technology
2010 Short-term Training, School of Pharmacy, University of Washington
2003 M.S., Graduate Institute of Pharmacy, National Defense Medical Center
2000 B.S., School of Pharmacy, National Defense Medical Center
🏛 Experience
2024.01–Present Assistant Professor, School of Pharmacy, National Defense Medical Center
2022.07–2023.12 Director, Clinical Pharmacy Section, Department of Pharmacy Practice, Tri-Service General Hospital
2021.11–2022.07 Inspector, Pharmaceutical Administration Division, Medical Affairs Bureau, Ministry of National Defense
2019.08–Present Assistant Professor, School of Pharmacy, National Defense Medical Center
2018.04–2021.11 Director, Dispensing Section, Department of Pharmacy Practice, Tri-Service General Hospital
2017.03–2018.03 Reviewer, Pharmaceutical Administration Division, Medical Affairs Bureau, Ministry of National Defense
2013.08–2018.03 Senior Pharmacist, Department of Pharmacy Practice, Tri-Service General Hospital
2012.08–2013.07 Chief Pharmacist, Department of Pharmacy Practice, Tri-Service General Hospital
2010.05–2012.07 Pharmacist / Section Chief, Compounding Division, Department of Pharmacy Practice, Tri-Service General Hospital
2005.07–2010.04 Pharmacist, Department of Pharmacy Practice, Tri-Service General Hospital
2003.07–2005.06 Military medical and pharmacy-related positions, Army units and Medical Affairs services
🔬 Research Fields
Pharmaceutics, Drug Delivery, Nanoformulation, Clinical Pharmacy and Therapeutics
🧾 Publications
※ Scroll to view more 
  1. W.-A. LIN, S.-L. TANG, Y.-H. TARN. Cost-utility analysis of different peg-interferon alpha-2b plus ribavirin treatment strategies as initial therapy for naïve Chinese patients with chronic hepatitis C. Alimentary Pharmacology and Therapeutics. 2006, 24(10), 1483–1493.
  2. Hu, Chieh-Shen, Tang, Sung-Ling, Chiang, Chiao-His, Hosseinkhani, Hossein, Hong, Po-Da. Characterization and anti-tumor effects of chondroitin sulfate–chitosan nanoparticles delivery system. Journal of Nanoparticle Research. 2014, 16(11):2672.
  3. Tang, Sung-Ling, Bai, Meng-Yi, Wang, Jyun-Yi, Hong, Po-Da. Development and application of micro-polysaccharide drug carriers incorporating doxorubicin and superparamagnetic iron oxide for bimodality treatment of hepatocellular carcinoma. Colloids and Surfaces B: Biointerfaces. 2017, 151:304-313.
  4. Meng-Yi Bai, Sung-Ling Tang, Meng-Han Chuang, Ting-Ying Wang, Po-da Hong. Evaluation of chitosan derivative microparticles encapsulating superparamagnetic iron oxide and doxorubicin as a pH-sensitive delivery carrier in hepatic carcinoma treatment: an in vitro comparison study. Frontiers in Pharmacology. 2018.
  5. Meng-Yi Bai, Meng-Han Chuang, Ming-Fang Lin, Sung-Ling Tang, Chin-Chean Wong, Wing P. Chan. Relationships of age and sex with cytokine content and distribution in human platelet fibrin gels. Scientific Reports. 2018.
  6. Yu-Chi Wang, Meng-Yi Bai, Ying-Ting Yeh, Sung-Ling Tang, Mu-Hsien Yu. CD133 targeted PVP/PMMA microparticle incorporating levamisole for the treatment of ovarian cancer. Polymers. 2020.
  7. Bashir Lawal et al. Transcriptomic-based identification of the immuno-oncogenic signature of cholangiocarcinoma for HLC-018 multi-target therapy exploration. Cells. 2021.
  8. Ntlotlang Mokgautsi et al. Anticancer activities of SJ10 in glioblastoma multiforme chemoradioresistant oncogenic signatures. Cancers. 2022.
  9. Meng-Yi Bai et al. Current progress of platelet-rich derivatives in cartilage and joint repairs. International Journal of Molecular Sciences. 2023.
  10. Sung-Ling Tang, Kai-Yi Wang, Wen-Kai Hsiao, Chi-Kang Lin. Breast milk excretion of dinalbuphine sebacate injection administered after cesarean section. Journal of Clinical Pharmacology. 2024.
  11. Meng-Yi Bai et al. Development and application of a crosslinked gelatin foam dressing for wound recovery. Natural Sciences. 2025.
  12. Sung-Ling Tang et al. Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer. Comput Biol Med. 2025.
  13. Ren-Jong Liang et al. Selection of an optimal metabolic model for accurately predicting the hepatic clearance of albumin-binding-sensitive drugs. Pharmaceuticals. 2025.
  14. Hsin-Chung Cheng et al. Advancing hepatic clearance prediction across in vitro, ex situ, and in vivo systems. European Journal of Pharmaceutical Sciences. 2025.
  • Views:259
  • Update Date:2026-08-19
  • Contact Us